These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539 [TBL] [Abstract][Full Text] [Related]
4. [Allergen-specific immune therapy in the treatment of asthma]. Malling HJ Ugeskr Laeger; 2000 Jan; 162(4):477-9. PubMed ID: 10697443 [TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. Devillier P; Dreyfus JF; Demoly P; Calderón MA BMC Med; 2014 May; 12():71. PubMed ID: 24885894 [TBL] [Abstract][Full Text] [Related]
7. Specific allergen immunotherapy for the treatment of atopic eczema. Tam H; Calderon MA; Manikam L; Nankervis H; García Núñez I; Williams HC; Durham S; Boyle RJ Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008774. PubMed ID: 26871981 [TBL] [Abstract][Full Text] [Related]
8. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Pradalier A; Basset D; Claudel A; Couturier P; Wessel F; Galvain S; André C Allergy; 1999 Aug; 54(8):819-28. PubMed ID: 10485385 [TBL] [Abstract][Full Text] [Related]
9. [Specific immunotherapy using allergens apropos of specific immunotherapy by the sublingual route]. Sabbah A Allerg Immunol (Paris); 1998 Sep; 30(7):221-8. PubMed ID: 9823421 [TBL] [Abstract][Full Text] [Related]
10. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. La Rosa M; Ranno C; André C; Carat F; Tosca MA; Canonica GW J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):425-32. PubMed ID: 10452766 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis. Yang J; Lei S Front Immunol; 2023; 14():1274241. PubMed ID: 38162647 [TBL] [Abstract][Full Text] [Related]
12. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Guez S; Vatrinet C; Fadel R; André C Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522 [TBL] [Abstract][Full Text] [Related]
17. Titration of immunotherapy by periodical nasal allergic challenges in the treatment of allergic rhinitis. Clarke PS Med J Aust; 1992 Jul; 157(1):11-3. PubMed ID: 1640882 [TBL] [Abstract][Full Text] [Related]
18. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application]. Fuchs T; Klimek L HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067 [No Abstract] [Full Text] [Related]
19. SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials. Csonka P; Hamelmann E; Turkalj M; Roberts G; Mack DP Acta Paediatr; 2024 Jun; 113(6):1209-1220. PubMed ID: 38529710 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of local nasal immunotherapy. Andri L; Senna GE; Dama AR Allergy; 1997; 52(33 Suppl):36-9. PubMed ID: 9188947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]